ArticleFrontiers in pharmacology2022

Chinese Herbal Medicine (Yiqi-Yangyin-Jiedu Decoction) Combined With Osimertinib as First-Line Treatment in EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (CATLA-2): A Study Protocol for a Double-Blind Randomized Controlled Trial.

Jialin Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.